OBJECTIVE: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. ANALYSIS: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. RESULTS: The reduction in psychiatric symptoms was comparable across all treatment groups (p >.05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. CONCLUSION: ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.
OBJECTIVE: To test whether mental health improvements observed in a nationally representative sample of 2466 HIV+ persons receiving care in the United States during the dissemination of combination antiretroviral therapy (ART) is a result of global optimism or directly related to treatment. ANALYSIS: Data were analyzed by means of a linear regression model of the change in psychiatric symptoms from baseline (January 1996-April 1997) to the first follow-up interview approximately 8 months later as a function of changes in CD4+ counts, opportunistic infection treatments, and HIV physical symptoms in the overall sample and separately in participants who maintained ART, initiated ART, never received ART, or transitioned to a less recommended regimen during the study period. RESULTS: The reduction in psychiatric symptoms was comparable across all treatment groups (p >.05), suggesting a global effect. In patients who initiated or maintained ART, fewer psychiatric symptoms were significantly related to higher CD4+ and fewer opportunistic infection treatments and HIV symptoms, however, suggesting a treatment effect. CONCLUSION:ART appears to be responsible for both a treatment-specific and global improvement in the mental health of HIV+ patients, possibly through the promise of extended survival and a better quality of life.
Authors: Pauline M Maki; Leah H Rubin; Mardge Cohen; Elizabeth T Golub; Ruth M Greenblatt; Mary Young; Rebecca M Schwartz; Kathryn Anastos; Judith A Cook Journal: Menopause Date: 2012-11 Impact factor: 2.953
Authors: Judith A Cook; Dennis D Grey; Jane K Burke-Miller; Mardge H Cohen; David Vlahov; Farzana Kapadia; Tracey E Wilson; Robert Cook; Rebecca M Schwartz; Elizabeth T Golub; Kathryn Anastos; Claudia Ponath; Lakshmi Goparaju; Alexandra M Levine Journal: Drug Alcohol Depend Date: 2007-02-08 Impact factor: 4.492
Authors: Michael S Yi; Joseph M Mrus; Terrance J Wade; Mona L Ho; Richard W Hornung; Sian Cotton; Amy H Peterman; Christina M Puchalski; Joel Tsevat Journal: J Gen Intern Med Date: 2006-12 Impact factor: 5.128
Authors: Lynn E Sullivan; Richard Saitz; Debbie M Cheng; Howard Libman; David Nunes; Jeffrey H Samet Journal: Addiction Date: 2008-07-10 Impact factor: 6.526